Merck Return on Investment 2006-2020 | MKGAF

Current and historical return on investment (ROI) values for Merck (MKGAF) over the last 10 years.
Merck ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2020-03-31 $2.74B $31.70B 9.25%
2019-12-31 $2.37B $29.75B 8.45%
2019-09-30 $2.16B $29.80B 7.80%
2019-06-30 $2.06B $27.06B 7.67%
2019-03-31 $1.83B $25.81B 6.81%
2018-12-31 $2.04B $28.24B 7.49%
2018-09-30 $1.98B $26.09B 7.50%
2018-06-30 $2.47B $27.41B 9.38%
2018-03-31 $2.69B $27.09B 10.55%
2017-12-31 $2.86B $24.98B 11.52%
2017-09-30 $2.99B $25.69B 12.02%
2017-06-30 $2.68B $24.11B 10.97%
2017-03-31 $2.61B $24.34B 10.59%
2016-12-31 $2.75B $25.30B 11.15%
2016-09-30 $2.64B $24.08B 10.77%
2016-06-30 $2.53B $25.02B 10.15%
2016-03-31 $2.46B $24.08B 10.08%
2015-12-31 $2.10B $24.94B 8.62%
2015-09-30 $1.88B $25.79B 8.10%
2015-06-30 $1.81B $22.99B 8.44%
2015-03-31 $1.76B $23.76B 8.71%
2014-12-31 $1.83B $20.42B 9.75%
2014-09-30 $2.26B $18.51B 12.26%
2014-06-30 $2.52B $18.04B 13.66%
2014-03-31 $2.88B $18.04B 15.64%
2013-12-31 $2.88B $19.03B 15.57%
2013-09-30 $5.99B $18.62B 32.93%
2013-06-30 $5.76B $18.07B 42.57%
2013-03-31 $4.97B $18.33B 55.13%
2012-12-31 $7.60B $17.72B 171.58%
2012-09-30 $7.27B inf%
2012-06-30 $10.25B inf%
2012-03-31 $10.32B inf%
2011-12-31 $10.55B inf%
2011-09-30 $10.95B inf%
2011-06-30 $7.98B inf%
2011-03-31 $10.53B inf%
2010-12-31 $9.81B inf%
2010-09-30 $9.09B inf%
2010-06-30 $11.25B inf%
2010-03-31 $11.14B inf%
2009-12-31 $10.81B inf%
2009-09-30 $10.33B inf%
2009-06-30 $10.41B inf%
2009-03-31 $10.79B inf%
2008-12-31 $11.12B inf%
2008-09-30 $10.63B inf%
2008-06-30 $10.17B inf%
2008-03-31 $9.62B inf%
2007-12-31 $9.68B inf%
2007-09-30 $9.75B inf%
2007-06-30 $9.31B inf%
2007-03-31 $8.80B inf%
2006-12-31 $7.86B inf%
2006-09-30 $7.60B inf%
2006-06-30 $7.44B inf%
2006-03-31 $7.39B inf%
2005-12-31 $7.31B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.026B $18.092B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.682B 37.84
Takeda Pharmaceutical (TAK) Japan $54.637B 9.57
Astellas Pharma (ALPMY) Japan $29.826B 15.11
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Grifols, S.A (GRFS) Spain $13.215B 16.43
Catalent (CTLT) United States $12.286B 47.50
Neurocrine Biosciences (NBIX) United States $12.176B 56.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 45.56
IPSEN SA ADR (IPSEY) France $7.709B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.939B 9.50
United Therapeutics (UTHR) United States $5.210B 9.87
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.818B 526.00
Nektar Therapeutics (NKTR) United States $4.199B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
FibroGen (FGEN) United States $3.748B 0.00
Hypermarcas (HYPMY) Brazil $3.724B 13.70
ChemoCentryx (CCXI) United States $3.625B 0.00
PTC Therapeutics (PTCT) United States $3.566B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.505B 10.29
Pacira BioSciences (PCRX) United States $2.331B 47.70
Sage Therapeutics (SAGE) United States $2.266B 0.00
Cronos Group (CRON) Canada $2.233B 64.00
Corcept Therapeutics (CORT) United States $1.869B 18.53
Xencor (XNCR) United States $1.825B 0.00
USANA Health Sciences (USNA) United States $1.786B 18.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.631B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.629B 12.46
Akebia Therapeutics (AKBA) United States $1.551B 0.00
Zogenix (ZGNX) United States $1.516B 0.00
Heron Therapeutics (HRTX) United States $1.487B 0.00
Indivior (INVVY) United States $1.421B 17.64
Karyopharm Therapeutics (KPTI) United States $1.412B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Theravance Biopharma (TBPH) Cayman Islands $1.339B 0.00
Esperion Therapeutics (ESPR) United States $1.310B 0.00
VAXART, INC (VXRT) United States $1.259B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 46.13
Tilray (TLRY) Canada $0.945B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.923B 0.00
Endo (ENDP) Ireland $0.774B 1.20
ImmunoGen (IMGN) United States $0.749B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.695B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
Radius Health (RDUS) United States $0.614B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Ardelyx (ARDX) United States $0.568B 0.00
Molecular Templates (MTEM) United States $0.558B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.524B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.513B 12.40
Flexion Therapeutics (FLXN) United States $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.500B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Siga Technologies (SIGA) United States $0.477B 0.00
Altimmune (ALT) United States $0.451B 0.00
DURECT (DRRX) United States $0.419B 0.00
TherapeuticsMD (TXMD) United States $0.405B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
Harpoon Therapeutics (HARP) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.359B 0.00
Calithera Biosciences (CALA) United States $0.359B 0.00
Organogenesis Holdings (ORGO) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.287B 0.00
IMV INC (IMV) Canada $0.286B 0.00
PROFOUND MEDICL (PROF) Canada $0.267B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.231B 0.00
Redhill Biopharma (RDHL) Israel $0.225B 0.00
OptiNose (OPTN) United States $0.218B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.206B 0.00
Lannett Co Inc (LCI) United States $0.198B 4.34
Nature's Sunshine Products (NATR) United States $0.188B 24.77
Jounce Therapeutics (JNCE) United States $0.174B 4.16
Nivalis Therapeutics (ALPN) United States $0.168B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.149B 0.00
Aquestive Therapeutics (AQST) United States $0.139B 0.00
Otonomy (OTIC) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.103B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Heat Biologics (HTBX) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
PolarityTE (PTE) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
Natural Alternatives (NAII) United States $0.047B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
Novan (NOVN) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
GTx (ONCT) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 31.57
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00